One Aducanumab Patient, Six Brain Edema Episodes

(MedPage Today) -- A man treated with the recently approved Alzheimer's drug aducanumab (Aduhelm) had six amyloid-related imaging abnormality (ARIA) episodes, researchers reported.
Over 44 months in a long-term extension study, the Alzheimer's...